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Abstract 
Two new ent-kauren-19-oic acid derivatives, ent-14S*-hydroxykaur-16-en-19-oic acid and 
ent-14S*,17–dihydroxykaur-15-en-19-oic acid together with eleven known compounds ent-
kaur-16-en-19-oic acid, ent-kaur-16-en-19-al, ent-12β-hydroxykaur-16-en-19-oic acid, ent-
12β-acetoxykaur-16-en-19-oic acid, 8R,13R-epoxylabd-14-ene,  eudesm-4(15)-ene-1β,6α-
diol, (–)-7-epivaleran-4-one, germacra-4(15),5E, 10(14)-trien-9β-ol, acetyl aleuritolic acid, 
β-amyrin, and stigmasterol were isolated from the stem bark of Croton pseudopulchellus 
(Euphorbiaceae). Structures were determined using spectroscopic techniques. Ent-14S*-
hydroxykaur-16-en-19-oic acid, ent-kaur-16-en-19-oic acid, ent-12β-hydroxykaur-16-en-19-
oic acid, ent-12β-acetoxykaur-16-en-19-oic acid and 8R,13R-epoxylabd-14-ene were tested 
for their effects on Semliki Forest virus replication and for cytotoxicity against human liver 
tumour cells (Huh-7 strain) but were found to be inactive.  Ent-kaur-16-en-19-oic acid, the 
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major constituent, showed weak activity against the Plasmodium falciparum (CQS) D10 
strain. 
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1. Introduction  
     Croton pseudopulchellus Pax is a shrub that grows to about 4 m tall and is commonly 
called the Small Lavender Croton. It is widespread in drier woodlands of the warmer 
regions of East, South-central and parts of West Africa (Burkill, 1994; Schmidt et al., 
2002).  In the coastal area of Kenya C. pseudopulchellus is employed as a condiment 
when material is burnt and the smoke used to flavour fresh milk (Pakia and Cooke, 2003).  
Poles from this species are durable and termite-proof, and accordingly used for hut 
building in Tanzania (Arbonnier, 2004). A decoction from the roots is used to treat 
asthma (Githens, 1948; Watt and Breyer-Brandwijk, 1962) and the powdered root taken 
as a snuff for headaches (Burkill, 1994).  Leaves are applied by Tanzanians to their chest, 
for chest ailments (Burkill, 1994). Such treatment of tussive conditions, likely associated 
with viral infections, has prompted the current investigation of anti-viral activity of 
compounds isolated from C. pseudopulchellus.   
     Githens (1948)  reported that leaves and roots of C. pseudopulchellus contain the 
toxalbumin crotin.  The chloroform extract of the stem bark of C. pseudopulchellus has 
been found to give a 82% inhibition against PfUP1 at 50 µg/ml, a chloroquine resistant 
strain of the malarial parasite Plasmodium falciparum
 
and in cytotoxicity tests showed an 
ID50 of 64µg/ml against vervet monkey kidney cells (Prozesky et al., 2001).
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     We report  the isolation of a number of ent-kauren-19-oic acid derivatives from the 
stem bark of C. pseudopulchellus, their effects on Semliki Forest virus replication using 
baby hamster kidney (BHK) cells as the host, cytotocity assays against BHK and human 
liver tumour cells (Huh-7 strain) and the activity of ent-kaur-16-en-19-oic acid against 
the Plasmodium falciparum (CQS) D10 strain. 
 
2. Results and discussion 
     Two new ent-kauren-19-oic acid derivatives, ent-14S*-hydroxykaur-16-en-19-oic acid 
(1), and ent-14S*,17–dihydroxykaur-16-en-19-oic acid (2) together with eleven known 
compounds ent-kaur-16-en-19-oic acid (Vieira et al., 2002), ent-kaur-16-en-19-al (Piozzi 
et al., 1971), ent-12β-hydroxykaur-16-en-19-oic acid (Ortega et al., 1985), ent-12β-
acetoxykaur-16-en-19-oic acid (Bohlmann et al., 1980), 8R,13R-epoxylabd-14-ene (Zhou 
et al., 1995), eudesm-4(15)-ene-1β,6α-diol (Sun et al., 2004), (-)-7-epivaleran-4-one 
(Srikrishan et al., 2004),
 
germacra-4(15), 5E, 10(14)-trien-9β-ol (Brown et al., 2003), β-
amyrin, acetyl aleuritolic acid and stigmasterol were isolated from the hexane and 
methylene chloride extracts of the stem bark
 
of Croton pseudopulchellus.  Ent-kaur-16-
en-19-oic acid was isolated from this plant in large quantities (7 % of combined hexane 
and dichloromethane extracts).  
     Ent-14S*-hydroxykaur-16-en-19-oic acid (1) was isolated as a white solid. HR-ESI-
MS indicated a molecular formula of C20H30O3, indicating six degrees of unsaturation.  
The IR spectrum showed absorption bands at 3340 and 1691 cm
-1 
due to hydroxyl and 
carbonyl stretches respectively.
 
 Similarities between the NMR spectra and those for the 
co-isolated ent-kaur-16-en-19-oic acid suggested the presence of a hydroxylated 
derivative (Vieira et al., 2002).  The 
13
C NMR spectra showed twenty carbon resonances, 
including alkene carbon resonances at δ 107.5 (CH2, C-17) and 149.2 (C-16), a carbonyl 
carbon resonance at δ 183.7 (C-19) and an oxymethine carbon resonance at δ 69.4 (C-14).  
The 
1
H NMR spectrum of compound 1 showed the presence of two methyl group proton 
resonances at δ 0.99 (s, 3H-20) and δ 1.24 (s, 3H-18), an oxymethine proton resonance (δ 
4.00, dt, J = 9.4, 2.0 Hz, H-14) and exocyclic methylene proton resonances (δ 4.84, d, J = 
1.9 Hz; δ 4.68, d, J = 1.9 Hz, 2H-17).  
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      The placement of the additional hydroxyl group at C-14 was confirmed by coupling 
seen in the COSY spectrum between the H-14 resonance at δ 4.00 (d, J = 9.4 Hz) and the 
typical H-13 (δ 2.25, dd, J = 3.3, 2.0 Hz) resonance (Vieira et al., 2002) and HMBC 
correlations seen between the H-14 resonance and resonances assigned to C-8 (δ 38.7), 
C-15 (δ 46.9), C-16 (δ 149.2), C-12 (δ 39.0) and C-13 (δ 44.9).     Placement of the 
hydroxyl group at C-12 was ruled out as both ent-12α-hydroxykaur-16-en-19-oic acid 
and ent-12β-hydroxykaur-16-en-19-oic acids have been reported and their 1H NMR 
spectroscopic data differ (Ortega et al., 1985) from those of compound 1.   
     The optical rotation of -160 confirmed that compound 1 belonged to the ent series, 
with H-13 on the α face of the molecule (Vieira et al., 2002).  When the hydroxyl group 
at C-14 is placed in the β-position, a model indicates that the H-13,14 dihedral angle is 
around 90° (Spartan08 calculation indicates 104.7°) resulting in the small coupling 
constant of 2.0 Hz observed (Takeda et al., 1989; Takeda et al., 1987) whereas the 
observed coupling constant of 9.4 Hz is attributable to long-range coupling with the H-
12α resonance. NOE effects were observed between the H-14α proton resonance and 
resonances ascribed to H-11α (δ 1.42), H-12α (δ 1.45) and H-13, (δ 2.25) further 
confirming the assignment.  Therefore the structure of compound 1 was determined to be 
ent-14S*-hydroxykaur-16-en-19-oic acid.   
     Jones oxidation of compound 1 yielded ent-14-oxokaur-16-en-19-oic acid, 1a, 
previously synthesized from stevioside (Yun-Xing et al., 1995; Bowden et al., 1946).
 
 
Assignment of the NMR spectra was undertaken as literature data for 1a is incomplete 
[Table 1].  The HMBC spectrum of 1a showed correlations between the C-14 resonance 
(δ 213.1) and the H-13 (δ 2.94, s) and the two H-15 (2.69 dd J = 2.4, 17.0 and 1.78 m) 
resonances.  
     Compound 2, ent-14S*,17–dihydroxykaur-15-en-19-oic acid, was isolated as its 
diacetate derivative after acetylation of an inseparable mixture. Compound 2 was found 
to be the 14α-hydroxy derivative of the kaurene diterpenoid, ent-17–hydroxykaur-15-en-
19-oic acid, reported previously from Baccharis illinita (Verdi et al., 2004).  HR-ESI-MS 
analysis of compound 2a indicated a molecular formula of C24H34O6.  The IR spectrum of 
2a showed a hydroxyl band at 3423 cm
-1 
and two carbonyl bands at 1736 cm
-1 
and 1692 
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cm
-1 
attributable to acetate carbonyl and carboxylic acid carbonyl group stretches 
respectively.  
     The 
13
C NMR spectrum of 2a showed twenty-four carbon atoms including a 
carboxylic acid carbonyl carbon resonance (δ 183.0, C-19), two acetyl carbonyl carbon 
resonances (δ 171.1, 170.6), two alkene carbon resonances (δ 142.1, C-15; 140.2, C-16), 
an oxymethylene carbon resonance (δ 62.4, C-17) and an oxymethine carbon resonance 
(δ 69.3, C-14). The 1H NMR spectrum showed an alkene proton singlet resonance at δ 
5.47 (H-15), an  oxymethine proton resonance at δ 4.97 (dt, J = 7.2, 3.5 Hz, H-14), and an 
oxymethylene proton resonance at δ 4.66 (s, 2H-17). The characteristic ent-kaurenoic 
acid H-13 resonance at δ 2.63 (t, J = 3.5 Hz) was observed (Ortega et al., 1985).  The 
placement of the hydroxyl group at C-14 was confirmed by a correlation seen in the 
COSY spectrum between the H-13 and H-14 resonances and correlations seen in the 
HMBC spectrum between the H-14 resonance and resonances ascribable to C-8 (48.2), 
C-13 (δ 46.2) and C-15 (142.1).  
     The negative optical rotation of – 55.9 indicated that compound 2a belonged to the ent 
series of kaurenoic acid-type diterpenoids (Garcia et al., 2007), as for all the diterpenoids 
isolated from this extract.  The H-14 proton resonance displayed a correlation in the 
NOESY spectrum with the H-7α (1.58, m), H-11α (2.01, m), H-12α (1.32, dd, J = 3.5, 
11.0 Hz) and H-13α resonances, thus the C-14 hydroxy group was assigned the β – 
configuration.  This was again supported by the small J13,14 coupling constant (Takeda et 
al., 1989; Takeda et al., 1987).  
     Ent-14S*-hydroxykaur-16-en-19-oic acid (1), ent-kaur-16-en-19-oic acid, ent-12β-
hydroxykaur-16-en-19-oic acid, ent-12β-acetoxykaur-16-en-19-oic acid and 8R,13R-
epoxylabd-14-ene were tested for their capacity to inhibit Semliki Forest virus (SFV) 
replication using baby hamster kidney (BHK) cells as the host for the viral infection. SFV 
is a positive-strand RNA virus that is widely studied as a prototype of Alphavirus genus. 
However, all the compounds were found to be inactive against the virus at a 
concentration of 50µM (Table 2). Cytotoxicity assays against BHK and human liver 
tumour cells (Huh-7 strain) in a single dose of 50 µM were also performed on the six 
compounds to check for preliminary toxicity against animal cells and they displayed low 
activity (Table 2). In addition, the compounds were not able to inhibit the enzyme β-
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lactamase, a potential target for antimicrobial combination therapy. Ent-kaur-16-en-19-
oic acid, the major component of the extract, showed a moderate in vitro anti-plasmodial 
activity against the chloroquine sensitive strain of P. falciparum with an IC50 value of 
31.77 μg/ml (compared to chloroquine IC50 14.26 ng/ml). 
 
3. Experimental 
3.1 General experimental procedures 
     Optical rotations were measured on a JASCO P-1020 polarimeter. FTIR spectra were 
recorded using a Perkin-Elmer (2000) spectrometer. 1D and 2D NMR spectra were 
recorded in CDCl3 on a 500 MHz Bruker AVANCE NMR instrument at room 
temperature. Chemical shifts (δ) are expressed in ppm and were referenced against the 
solvent resonances at 7.26 and 77.23 ppm for 
1
H and 
13
C NMR respectively. ESI mass 
spectra were recorded on a Bruker MicroToF mass spectrometer using an Agilent 1100 
HPLC to introduce samples (University of Oxford). 
 
3.2 Plant material 
     The stem bark of cultivated material of C. pseudopulchellus was collected in August 
2005 in Durban, of KwaZulu-Natal, South Africa, and a voucher retained at the 
KwaZulu-Natal herbarium for verification purposes (Crouch 1050, NH). . 
 
3.3 Extraction, isolation and characterization of compounds 
    The ground stem bark (2.6kg) was successively extracted with hexane, methylene 
chloride and methanol. TLC analysis of the hexane (22.4g) and methylene chloride 
extracts (11.4g showed they were similar, so they were combined and separated using 
column chromatography over silica gel (Merck 9385) using a hexane/ methylene 
chloride/methanol step gradient collecting fractions of 75 mL.  NMR analysis of the 
methanol extract showed that it contained only sugars and was not analysed further.  
Fractions 10 – 19 (20% DCM: 80% Hex) gave ent-kaur-16-en-19-al (27.0 mg), 8R, 13R - 
epoxylabd-14-ene (11.6 mg) and (–)-7-epivaleran-4-one (13.2 mg). Fractions 50 – 120 
(50% DCM: 50% Hex) gave ent-kaur-16-en-19-oic acid (2.2 g), acetyl aleuritolic acid 
(36.9 mg) and germacra-4(15), 5E, 10(14)-trien-9β-ol (10.1 mg); fractions 110 – 130 
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(60% DCM: 40% Hex) gave β-amyrin (4.9 mg) and stigmasterol (16.0 mg), fractions 125 
– 138 (70% DCM: 30% Hex) gave eudesm-4(15)-ene-1β,6α-diol (6.8 mg), fractions 150 
– 153 (100% DCM) yielded ent-12α-hydroxykaur-16-en-19-oic acid (25.0 mg), fractions 
155 – 158 (100% DCM) gave ent-12β-acetoxykaur-16-en-19-oic acid (25.6 mg), 
fractions 160 – 170 (100% DCM) gave ent-14S*-hydroxykaur-16-en-19-oic acid (38.0 
mg), fractions 200 – 212 (2% MeOH: 98% DCM) gave impure ent-14S*,17–
dihydroxykaur-15-en-19-oic acid  which was purified using column chromatography 
(100% DCM) after acetylation to yield ent-14S*,17–diacetoxykaur-15-en-19-oic acid (6.0 
mg).  Ent-14S*-hydroxykaur-16-en-19-oic acid (1) was oxidised using Jones reagent 
(Bowden et al., 1946) to yield compound 1a.  A mixture containing ent-14S*,17–
dihydroxykaur-15-en-19-oic acid (15 mg) was acetylated using pyridine (1 ml) and acetic 
anhydride (1 ml) and the reaction left to stand for 24 hours.  2a was isolated using 
column chromatography.
 
 
 3.3.1 Ent-14S*-hydroxykaur-16-en-19-oic acid (1) 
White solid; mp 126–129° C; [α]D
24.7
 = - 160 (0.01, CHCl3), IR  3340, 3078, 2929, 2851, 
1691;
 1
H and 
13
C NMR see Table 1; HRESIMS m/z [M - H]
+
 317.2124 (calcd for 
C20H29O3, 317.2122) 
 
3.3.2 Ent-14-oxokaur-16-en-19-oic acid (1a)  
Yellow oil;  [α]D
24
 = - 101 (0.01, CHCl3), IR 3422, 3070, 2926, 2845, 1722 and 1692 cm
-
1
; 
1
H and 
13
C NMR see Table 1; EIMS (70eV) m/z 316 (C20H28O3), 281, 249, 203, 189, 
135, 109, 95 (100), 55.  
 
3.3.3 Ent-14S*,17–dihydroxykaur-15-en-19-oic acid (2)  
Colourless oil: IR 3412, 1696 cm
-1
;
 1
H and 
13
C NMR see Table 1; GC-EI-MS (70eV) m/z   
334 (C20H30O4)  
 
3.3.4 Ent-14S*,17–diacetoxykaur-15-en-19-oic acid (2a)  
Colourless oil: [α] D
24
 = - 55.9 (0.005, CHCl3); IR 3423, 1736, 1692 cm
-1
; 
1
H and 
13
C 
NMR see Table 1; HRMS m/z 441.2251 (calcd for C24H34O6Na, 441.2253). 
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3.4 Biological assays  
     The SFV assay was done as previously described
 
(Pohjala et al., 2008) to measure the 
effect of test compounds on Semliki Forest Virus replication using baby hamster kidney 
(BHK) cells as host cells. The preliminary toxicity on animal cell viability was studied 
with two cell lines, baby hamster kidney (BHK) cells and Huh-7 hepatocytes (from 
human hepatocellular carcinoma), as previously described (Pohjala et al., 2007).
  
BHK 
and Huh-7 cells were exposed to test compounds for 24h and 48h, respectively. Cell 
viability after exposure was assessed by measuring the intracellular ATP levels with a 
CellTiter-Glo assay kit (Promega). Inhibition of the β-lactamase enzyme was tested 
according to Payne et al. (1994).  Inhibitors of this enzyme have possible applications in 
antimicrobial therapy.  
     Ent-kaur-16-en-19-oic acid was tested in duplicate against the chloroquine sensitive 
(CQS) strain of Plasmodium falciparum (D10). Continuous in vitro cultures of asexual 
erythrocyte stages of P. falciparum were maintained using a modified method of Trager 
and Jensen (Trager and Jensen, 1976).  Quantitative assessment of anti-plasmodial 
activity in vitro was determined via the parasite lactate dehydrogenase assay using a 
modified method described by Makler et al. (1993).
  
Ent-kaur-16-en-19-oic acid was also 
dissolved and diluted to a 2 mg/ml stock solution in 10% methanol and sonicated to 
enhance solubility and stock solution stored at – 20 ºC.  Further dilutions were prepared 
on the day of the experiment in complete medium.  Chloroquine (CQ) was used as the 
reference drug.  A full dose-response was performed for the compound to determine the 
concentration inhibiting 50 % of parasite growth (IC50 – value).  The Test sample was 
tested at a starting concentration of 100 μg/ml, which was serially diluted 2-fold in 
complete medium to give 10 concentrations, with the lowest concentration being 0.2 
μg/ml. CQ was tested at a starting concentration of 100 ng/ml.  The highest concentration 
of solvent to which the parasites were exposed had no measurable effect on the parasite 
viability (data not shown).  The IC50 - values were obtained using a non-linear dose-
response curve fitting analysis via graph pad prism v.4.0 software. 
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Table 1 
NMR Data (500 MHz) of 1, 1a, 2 and 2a (multiplicities, J in Hz) 
 
No. 1 1 1a 1a 2 2 2a 2a 
1α 39.9 CH2 1.66 m 39.6 CH2 1.55, d (12.9) 40.7 CH2 1.80 m 40.6 CH2 1.71 m 
1β  0.86 m  0.88 m  0.80 m  0.79 m 
2α 18.8 CH2 1.40 * 18.7 CH2 1.41, d (14.0) 20.7 CH2 1.84 m
* 19.1 CH2 1.42, d (12.0) 
2β  1.92 *  1.84*  1.84 m*  1.84 m  
3α 38.1 CH2 2.13, d (13.4)  37.9 CH2 2.16 m 38.1 CH2 2.11 m 38.0 CH2 2.17 m 
3β  1.01 m  1.03, td (4.0, 9.6)  1.00 m  1.01* 
4 43.7 C - 43.8 C - 44.0 C - 44.0 C - 
5 57.0 CH 1.04 m 56.7 CH 1.14, t  (7.6) 56.7 CH 1.08 m 56.7 CH 1.09, d (12.0) 
6α 20.5 CH2 1.76 m* 20.2 CH2 1.84
* 19.2 CH2 1.95 m 20.6 CH2 1.81 m
* 
6β  1.76 m*  1.84*  1.38 m  1.81 m* 
7α 39.9 CH2 1.15 m  38.3 CH2 1.30
* 38.5 CH2 1.30 m
* 38.9 CH2 1.59 m  
7β  1.52 m   1.66 m  1.30 m*  1.68 m  
8 38.7 C - 38.5 C - 48.3 C - 48.2 C  - 
9 51.7 CH 1.09 m 51.2 CH 1.32* 48.5 CH 1.15, d (9.5) 47.7 CH 1.19, d (10.0) 
10 34.6 C - 37.2 C - 39.1 C - 38.7 C - 
11α 21.1 CH2 1.42 m
* 27.4 CH2 1.69 m  28.7 CH2 1.60 m
* 25.2 CH2 1.56 m 
11β  1.90 m*  1.92, t (11.5)  1.60 m*  2.01 m 
12α 39.0 CH2 1.45 m  46.7 CH2 2.13 m  36.9 CH2 1.24 m  37.7 CH2 1.32, dd (3.5, 11.0) 
12β  1.84 m   2.20 m   2.43, d (10.5)  2.40, d (11.0) 
13 44.9 CH 2.25, dd (2.0, 3.3)  55.5 CH 2.94 s 47.9 CH 2.61 s 46.2 CH 2.63 t (3.5) 
14 69.4 CH 4.00, dt (9.4, 2.0) 213.1 C - 66.7 CH 4.07 br s (W1/2 = 14.0) 69.3 CH 4.97 dd (3.5, 7.2) 
15 46.9 CH2 1.80 m  46.0 CH2 1.78 m  138.6 CH 5.47 s 142.1 CH 5.47 s 
  1.96 m   2.69, dd (2.4, 17.0)  - - - 
16 149.2 C - 143.0 C - 145.7 C  140.2 C - 
17 107.5 CH2 4.84, d (1.9)  110.8 CH2 4.93 s 61.4 CH2 4.21, d (4.5)
* 62.4 CH2 4.66 s
* 
  4.68, d (1.9)  4.80 s  4.21, d (4.5)  4.66 s* 
18 29.0 CH3 1.24 s 29.1 CH3 1.25 s 28.6 CH3 1.21 s 29.2 CH3 1.26 s 
19 183.7 C - 183.5 C - 182.7 C - 183.0 C - 
20 13.6 CH3 0.99 s 12.6 CH3 0.75 s 14.7 CH3 1.08 s 13.7 CH3 1.02 s
* 
17-Ac   -  - - 170.6 C - 
17-Ac - - - - - - 21.2 CH3 2.08 s 
14-Ac - - - - - - 171.1 C - 
14-Ac - - - - - - 21.7 CH3  2.03 s 
OH - - - 11.1 br s - - - - 
*
Refer to overlapped/superimposed proton resonances 
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Table 2: Summary of bioassay results 
Compound SFV BHK cell Huh-7 cell β-lactamased 
 replication
a
 viability
b
 viability
c
  
Ent-kaur-16-en-19-oic acid 72.7 87.4 105.7 120.1 
Ent-12β-hydroxykaur-16-en-19-oic acid 76.5 93.0 96.9 122.8 
Ent-12β-acetoxykaur-16-en-19-oic acid 86.0 85.6 101.5 129.6 
Ent-14S*-hydroxykaur-16-en-19-oic acid 115.8 86.4 99.9 118.1 
8R,13R-epoxylabd-4-ene 56.7 85.0 87.6 89.8 
Positive control 17.4 21.3 19.8 13.4 
Results represent the surviving fraction (%) of virus / cells / enzyme activity compared to vehicle-treated 
control in each assay. All experiments were performed at 50 µM concentration in triplicate. Positive controls 
were 3’-amino-3’-deoxyadenosinea (20 µM), polymyxin B sulphateb,c (7500 IU/ml), and clavulanic acidd(50 
µM). SFV, Semliki Forest virus; BHK, baby hamster kidney; Huh-7, human hepatocyte cell line.   
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